41 related articles for article (PubMed ID: 10391684)
1. Gene mutation analysis and quantitation of DNA topoisomerase I in previously untreated non-small cell lung carcinomas.
Takatani H; Oka M; Fukuda M; Narasaki F; Nakano R; Ikeda K; Terashi K; Kinoshita A; Soda H; Kanda T; Schneider E; Kohno S
Jpn J Cancer Res; 1997 Feb; 88(2):160-5. PubMed ID: 9119744
[TBL] [Abstract][Full Text] [Related]
2. Quantification of cancer driver mutations in human breast and lung DNA using targeted, error-corrected CarcSeq.
Harris KL; Walia V; Gong B; McKim KL; Myers MB; Xu J; Parsons BL
Environ Mol Mutagen; 2020 Nov; 61(9):872-889. PubMed ID: 32940377
[TBL] [Abstract][Full Text] [Related]
3. A double dealing tale of p63: an oncogene or a tumor suppressor.
Chen Y; Peng Y; Fan S; Li Y; Xiao ZX; Li C
Cell Mol Life Sci; 2018 Mar; 75(6):965-973. PubMed ID: 28975366
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal rearrangements and copy number abnormalities of TP63 correlate with p63 protein expression in lung adenocarcinoma.
Aubry MC; Roden A; Murphy SJ; Vasmatzis G; Johnson SH; Harris FR; Halling G; Knudson RA; Ketterling RP; Feldman AL
Mod Pathol; 2015 Mar; 28(3):359-66. PubMed ID: 25189640
[TBL] [Abstract][Full Text] [Related]
5. ΔNp63α activates CD82 metastasis suppressor to inhibit cancer cell invasion.
Wu J; Liang S; Bergholz J; He H; Walsh EM; Zhang Y; Xiao ZX
Cell Death Dis; 2014 Jun; 5(6):e1280. PubMed ID: 24901051
[TBL] [Abstract][Full Text] [Related]
6. Role of p63 in Development, Tumorigenesis and Cancer Progression.
Bergholz J; Xiao ZX
Cancer Microenviron; 2012 Dec; 5(3):311-22. PubMed ID: 22847008
[TBL] [Abstract][Full Text] [Related]
7. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.
Ellinghaus E; Stanulla M; Richter G; Ellinghaus D; te Kronnie G; Cario G; Cazzaniga G; Horstmann M; Panzer Grümayer R; Cavé H; Trka J; Cinek O; Teigler-Schlegel A; ElSharawy A; Häsler R; Nebel A; Meissner B; Bartram T; Lescai F; Franceschi C; Giordan M; Nürnberg P; Heinzow B; Zimmermann M; Schreiber S; Schrappe M; Franke A
Leukemia; 2012 May; 26(5):902-9. PubMed ID: 22076464
[TBL] [Abstract][Full Text] [Related]
8. p53 Family: Role of Protein Isoforms in Human Cancer.
Wei J; Zaika E; Zaika A
J Nucleic Acids; 2012; 2012():687359. PubMed ID: 22007292
[TBL] [Abstract][Full Text] [Related]
9. The role of p63 in cancer, stem cells and cancer stem cells.
Nekulova M; Holcakova J; Coates P; Vojtesek B
Cell Mol Biol Lett; 2011 Jun; 16(2):296-327. PubMed ID: 21442444
[TBL] [Abstract][Full Text] [Related]
10. TAp63 induces senescence and suppresses tumorigenesis in vivo.
Guo X; Keyes WM; Papazoglu C; Zuber J; Li W; Lowe SW; Vogel H; Mills AA
Nat Cell Biol; 2009 Dec; 11(12):1451-7. PubMed ID: 19898465
[TBL] [Abstract][Full Text] [Related]
11. TATA-binding Protein (TBP)-like Protein Is Engaged in Etoposide-induced Apoptosis through Transcriptional Activation of Human TAp63 Gene.
Suenaga Y; Ozaki T; Tanaka Y; Bu Y; Kamijo T; Tokuhisa T; Nakagawara A; Tamura TA
J Biol Chem; 2009 Dec; 284(51):35433-40. PubMed ID: 19858204
[TBL] [Abstract][Full Text] [Related]
12. DeltaNp63 protein expression in uterine cervical and endometrial cancers.
Lin Z; Liu M; Li Z; Kim C; Lee E; Kim I
J Cancer Res Clin Oncol; 2006 Dec; 132(12):811-6. PubMed ID: 16804722
[TBL] [Abstract][Full Text] [Related]
13. The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection.
Guo C; Pan ZG; Li DJ; Yun JP; Zheng MZ; Hu ZY; Cheng LZ; Zeng YX
J Transl Med; 2006 May; 4():23. PubMed ID: 16729897
[TBL] [Abstract][Full Text] [Related]
14. p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors.
Keyes WM; Vogel H; Koster MI; Guo X; Qi Y; Petherbridge KM; Roop DR; Bradley A; Mills AA
Proc Natl Acad Sci U S A; 2006 May; 103(22):8435-40. PubMed ID: 16714381
[TBL] [Abstract][Full Text] [Related]
15. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms.
Koga F; Kawakami S; Kumagai J; Takizawa T; Ando N; Arai G; Kageyama Y; Kihara K
Br J Cancer; 2003 Mar; 88(5):740-7. PubMed ID: 12618884
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51.
Senoo M; Tsuchiya I; Matsumura Y; Mori T; Saito Y; Kato H; Okamoto T; Habu S
Br J Cancer; 2001 May; 84(9):1235-41. PubMed ID: 11336476
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
[TBL] [Abstract][Full Text] [Related]
18. Absence of p51 alteration in human ovarian cancer.
Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
[TBL] [Abstract][Full Text] [Related]
19. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
